A panel of FDA advisers voted in favor of Vertex Pharmaceuticals’ closely watched combination treatment for cystic fibrosis, looking past some efficacy doubts and setting the stage for a likely approval.
Source: Vertex clears an FDA hurdle with its cystic fibrosis combo